Clopidogrel

Adopted

First published: 07/12/2009
Last updated: 07/12/2009
EMEA/583696/2009

Invented name	Clopidogrel BMS
Active substance	clopidogrel
Therapeutic area	Cardiovascular diseases
Decision number	P/190/2009
PIP number	Clopidogrel
Pharmaceutical form(s)	Age-appropriate oral formulation Film-coated tablet
Condition(s) / indication(s)	Thromboembolic events
Route(s) of administration	Oral use
Contact for public enquiries	Bristol-Myers Squibb Pharma EEIG E-mail: sylvie.gabriel@sanofi-aventis.com Country: France Phone: +33 153774152 Fax: +33 153774133
Decision type	P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)